These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31400981)

  • 1. Subclinical Interstitial Lung Disease in Patients with Systemic Sclerosis. A Pilot Study on the Role of Ultrasound.
    Reyes-Long S; Gutierrez M; Clavijo-Cornejo D; Alfaro-Rodríguez A; González-Sámano K; Cortes-Altamirano JL; Muñoz-Louis R; Cruz-Arenas E; Camargo K; Gonzalez F; Bertolazzi C
    Reumatol Clin (Engl Ed); 2021 Mar; 17(3):144-149. PubMed ID: 31400981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
    Barskova T; Gargani L; Guiducci S; Randone SB; Bruni C; Carnesecchi G; Conforti ML; Porta F; Pignone A; Caramella D; Picano E; Cerinic MM
    Ann Rheum Dis; 2013 Mar; 72(3):390-5. PubMed ID: 22589373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis.
    Gutierrez M; Bertolazzi C; Zozoaga-Velazquez E; Clavijo-Cornejo D
    Tomography; 2024 Apr; 10(4):521-532. PubMed ID: 38668398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis.
    Tardella M; Di Carlo M; Carotti M; Filippucci E; Grassi W; Salaffi F
    Medicine (Baltimore); 2018 May; 97(18):e0566. PubMed ID: 29718851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
    Ruaro B; Baratella E; Confalonieri P; Confalonieri M; Vassallo FG; Wade B; Geri P; Pozzan R; Caforio G; Marrocchio C; Cova MA; Salton F
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Ultrasound as a Screening Method for Interstitial Lung Disease in Patients With Systemic Sclerosis.
    Hassan RI; Lubertino LI; Barth MA; Quaglia MF; Montoya SF; Kerzberg E; Binda MDC
    J Clin Rheumatol; 2019 Oct; 25(7):304-307. PubMed ID: 30028804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Krebs von den Lungen-6 and lung ultrasound B lines as potential diagnostic and prognostic factors for rheumatoid arthritis-associated interstitial lung disease.
    Fotoh DS; Helal A; Rizk MS; Esaily HA
    Clin Rheumatol; 2021 Jul; 40(7):2689-2697. PubMed ID: 33474659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease.
    Gasperini ML; Gigante A; Iacolare A; Pellicano C; Lucci S; Rosato E
    Clin Rheumatol; 2020 Jan; 39(1):119-123. PubMed ID: 31327084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease.
    Di Battista M; Delle Sedie A; Romei C; Tavanti L; Da Rio M; Morganti R; Della Rossa A; Mosca M
    Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38048612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung ultrasound in the assessment of interstitial lung disease in patients with connective tissue disease: Performance in comparison with high-resolution computed tomography.
    Watanabe S; Yomono K; Yamamoto S; Suzuki M; Gono T; Kuwana M
    Mod Rheumatol; 2024 May; ():. PubMed ID: 38813668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Use of Lung Ultrasound and Chest X-Ray in the Detection of Interstitial Lung Disease.
    Vizioli L; Ciccarese F; Forti P; Chiesa AM; Giovagnoli M; Mughetti M; Zompatori M; Zoli M
    Respiration; 2017; 93(1):15-22. PubMed ID: 27880957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of lung ultrasound to identify interstitial lung disease: An observational study based on the STROBE guidelines.
    Yan JH; Pan L; Gao YB; Cui GH; Wang YH
    Medicine (Baltimore); 2021 Mar; 100(12):e25217. PubMed ID: 33761708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Lung Ultrasound in Systemic Sclerosis: A Systematic Review.
    Gomes Guerra M; Machado Pinto T; Águeda A; Rodrigues J; Marona J; Violante A; Oliveira M
    J Clin Rheumatol; 2023 Jun; 29(4):e32-e39. PubMed ID: 36870085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung ultrasound in systemic sclerosis: correlation with high-resolution computed tomography, pulmonary function tests and clinical variables of disease.
    Gigante A; Rossi Fanelli F; Lucci S; Barilaro G; Quarta S; Barbano B; Giovannetti A; Amoroso A; Rosato E
    Intern Emerg Med; 2016 Mar; 11(2):213-7. PubMed ID: 26494471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Transthoracic Lung Ultrasound Score and HRCT Features in Patients with Interstitial Lung Diseases.
    Man MA; Dantes E; Domokos Hancu B; Bondor CI; Ruscovan A; Parau A; Motoc NS; Marc M
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31405211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD).
    Wangkaew S; Losuriya P; Euathrongchit J
    Clin Rheumatol; 2021 Mar; 40(3):955-963. PubMed ID: 32803568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening.
    Gargani L; Romei C; Bruni C; Lepri G; El-Aoufy K; Orlandi M; D'Errico L; Bandini G; D'Angelo G; Guiducci S; Dagna L; Falaschi F; Matucci-Cerinic M; Moggi-Pignone A
    Rheumatology (Oxford); 2022 Apr; 61(SI):SI56-SI64. PubMed ID: 34698807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
    Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
    Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Prevalence of the Lung Ultrasound Interstitial Syndrome in Systemic Sclerosis Patients with Normal HRCT and Lung Function-A Pilot Study.
    Mercier C; Thoreau B; Flament T; Legué S; Pearson A; Jobard S; Marchand-Adam S; Plantier L; Diot E
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.